Novavax Submits Final Data Packages to U.S. FDA as Prerequisite to Emergency Use Authorization…
Novavax, Inc. a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, announced that it has completed submission of…
Read More...
Read More...
